Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
Recro Pharma, Inc. - Common Stock   (ticker: REPH)
Quote:() Quotes on: Yahoo | Google
5 day's Perf: 100%
1 Month Perf: 100%
3 Month Perf: 100%
YTD Perf: 100%
1 Year Perf: 100%
Stock chart
Useful Quick Links for REPH
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :       Strong Sell       (Click Here For Details)
INSIDERS' Score: 10
0 100 10
Latest 1 month: 0 0
Latest 6 Months: 0 0
52 Weeks: 40,000 144,806
Gurus' Indicator :       Strong Buy       (Click Here For Details)
GURUS' Score: 95
0 100 95
Current Holdings: 1,358,484
Previous Holdings: 867,000
Change: 56.69%
Institutions' Indicator :       Strong Buy       (Click Here For Details)
0 100 80
Current Holdings: 14,350,859
Previous Holdings: 10,756,386
Change: 33.42%
News And Links For The Group (Contribute a link)
[REPH]   Baudax Bio: Recro's Spin-Out Is A Buy At These Prices  (Seeking Alpha)   18-Feb-20 16:08
[REPH]   In Search Of Growth Leaders With Strong Momentum  (Seeking Alpha)   24-Jan-20 14:12
[REPH]   How To Find Top Momentum Stocks In Healthcare  (Seeking Alpha)   3-Dec-19 04:22
[REPH]   Recro Pharma: FDA Grants Appeal For IV Meloxicam, Adding Value To The Proposed Acute Care Spin-Out  (Seeking Alpha)   4-Nov-19 16:07
[REPH]   Recro Pharma: Buying Before Acute Care Spin-Out  (Seeking Alpha)   4-Sep-19 10:27
[REPH]   Recro Pharma: Restructuring Points To Profits  (Seeking Alpha)   7-Apr-19 13:17
[REPH]   Upcoming FDA Decision Creates Upside And Catalyst For Recro Pharma  (Seeking Alpha)   15-Mar-19 10:09
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*